Published in J Hypertens on August 01, 2016
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int (2009) 7.45
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int (2009) 7.19
Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol (2007) 3.66
Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant (2011) 2.51
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int (2010) 2.14
Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J Hypertens (2005) 2.04
Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med (2009) 1.76
Validation of the Oxford classification of IgA nephropathy. Kidney Int (2011) 1.53
Usefulness of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes. Am J Cardiol (2010) 1.51
Role of oxidative stress in erythropoietin-induced hypertension in uremic rats. Am J Hypertens (2009) 1.44
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis (2012) 1.32
Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int (2004) 1.30
Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapy. Clin J Am Soc Nephrol (2011) 1.18
Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis. Am J Kidney Dis (2013) 1.17
The impact of sex in primary glomerulonephritis. Nephrol Dial Transplant (2008) 1.14
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. Clin J Am Soc Nephrol (2011) 1.14
Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Am J Kidney Dis (2009) 1.09
Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension (2007) 1.08
Local shear stress and brachial artery functions in end-stage renal disease. J Am Soc Nephrol (2007) 1.02
Impact of age on glomerular filtration estimates. Nephrol Dial Transplant (2008) 1.01
Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination. Am J Transplant (2004) 0.98
Systemic anticoagulation and prevention of hemodialysis catheter malfunction. ASAIO J (2005) 0.97
Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis (2013) 0.95
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis. Clin J Am Soc Nephrol (2012) 0.94
Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study. Hypertension (2013) 0.94
Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT). BMC Nephrol (2013) 0.93
RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes. Arterioscler Thromb Vasc Biol (2011) 0.93
A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration. Intensive Care Med (2003) 0.93
Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest (2005) 0.92
Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Am J Nephrol (2012) 0.91
Impact of hemocontrol on hypertension, nursing interventions, and quality of life: a randomized, controlled trial. Clin J Am Soc Nephrol (2007) 0.91
Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients. Am J Kidney Dis (2005) 0.90
Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends. BMC Nephrol (2013) 0.88
Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort. Nephrol Dial Transplant (2013) 0.87
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat. Eur J Pharmacol (2009) 0.87
Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease. Clin Exp Hypertens (2013) 0.86
The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection. Circ Res (2011) 0.86
Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study. Diabetes Res Clin Pract (2013) 0.86
Validating the oxford classification of IgA nephropathy. Clin J Am Soc Nephrol (2011) 0.85
Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrol Dial Transplant (2011) 0.84
Age-related and blood pressure-independent reduction in aortic stiffness after kidney transplantation. J Hypertens (2011) 0.83
Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases. Am J Physiol Heart Circ Physiol (2010) 0.83
Alteration of the platelet transcriptome in chronic kidney disease. Thromb Haemost (2012) 0.83
Carbamazepine poisoning treated by multiple extracorporeal treatments. Clin Nephrol (2015) 0.82
eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass. Nephrol Dial Transplant (2011) 0.82
Measurement of blood volume during hemodialysis is a useful tool to achieve safely adequate dry weight by enhanced ultrafiltration. ASAIO J (2004) 0.82
Biofeedback regulation of ultrafiltration and dialysate conductivity for the prevention of hypotension during hemodialysis. ASAIO J (2002) 0.82
Uraemic plasma decreases the expression of ABCA1, ABCG1 and cell-cycle genes in human coronary arterial endothelial cells. Nephrol Dial Transplant (2006) 0.81
Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care. Clin J Am Soc Nephrol (2014) 0.81
The impact of arteriovenous fistulas on aortic stiffness in patients with chronic kidney disease. Nephrol Dial Transplant (2009) 0.81
Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study. Nephron (2015) 0.81
Incidence and severity of early electrolyte abnormalities following autologous haematopoietic stem cell transplantation. Nephrol Dial Transplant (2007) 0.81
Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients. Nephrol Dial Transplant (2002) 0.80
Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform. Nephrol Dial Transplant (2009) 0.80
Dual-kidney transplants as an alternative for very marginal donors: long-term follow-up in 63 patients. Transplantation (2010) 0.80
Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease. J Nephrol (2010) 0.79
[Candidemia and granulomatous tubulointerstitial nephritis]. Nephrol Ther (2008) 0.78
Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy. Transplantation (2015) 0.78
Arterial stiffness and dialysis calcium concentration. Int J Nephrol (2011) 0.78
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy. Nephron (2015) 0.78
Prescription patterns of pharmacological agents for left ventricular systolic dysfunction among hemodialysis patients. Am J Kidney Dis (2006) 0.78
Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients. Transplantation (2004) 0.77
Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis. Int Urol Nephrol (2013) 0.77
Measurement of the international normalized ratio (INR) in hemodialysis patients with heparin-locked central venous catheters: evaluation of a novel blood sampling method. J Vasc Access (2009) 0.77
Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Am J Hypertens (2006) 0.77
Morning plasma aldosterone predicts the subtype of primary aldosteronism independent of sodium intake. Clin Exp Hypertens (2007) 0.77
Soluble Fas: a novel predictor of atherosclerosis in dialysis patients. Am J Kidney Dis (2003) 0.77
Impact of donor age on long-term outcomes after delayed graft function: 10-year follow-up. Transpl Int (2012) 0.77
Inadequate treatment of congestive heart failure in dialysis patients. Semin Dial (2007) 0.76
The effect of sodium citrate 4% locking solution for central venous dialysis catheter on the international normalized ratio (INR) value. Nephrol Dial Transplant (2008) 0.75
Authors’ response. Crit Care (2015) 0.75
Authors' response. Crit Care (2015) 0.75
Systolic blood pressure diurnal variation is not a predictor of renal target organ damage in kidney transplant recipients. Am J Transplant (2004) 0.75
Rheological properties of silica dispersions stabilized by stereoregular poly(methyl methacrylate). J Colloid Interface Sci (2004) 0.75
Gene polymorphisms as clinical tools in chronic glomerulopathies: a prospective study. Nephron Clin Pract (2013) 0.75
[Are cardioprotective drugs underused after a myocardial infarction in patients who suffer from chronic kidney disease?]. Nephrol Ther (2010) 0.75
Acute effects of cinacalcet on arterial stiffness and ventricular function in hemodialysis patients: A randomized double-blinded crossover study. Medicine (Baltimore) (2017) 0.75
Uric acid association with pulsatile and steady components of central and peripheral blood pressures. J Hypertens (2017) 0.75
Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease. J Hypertens (2017) 0.75
Enhanced development of caspase-independent cortical cell death during cold storage in kidneys of non-heart-beating donors. Transplantation (2002) 0.75
Green dialysate: asymptomatic perforated cholecystitis without peritonitis. Nephrol Dial Transplant (2006) 0.75
In vivo quantification of central venous catheter leak. Nephrol Dial Transplant (2005) 0.75
Localization of ectopic fibroblast growth factor 23 production in tumor-induced osteomalacia using selective venous samplings. Clin Nephrol (2016) 0.75
Plasmapheresis in myeloma cast nephropathy. Clin Nephrol (2013) 0.75